what drug is ipamorelin - Research Peptide Ipamorelin Archives - Wellness Clinic

The Pulsatile Release of "No DAC" The specific type of CJC-1295 used in the CJC-1295/Ipamorelin 5/5mg blend is the "No DAC" variant, and for good reason

While the study found no significant differences in the primary efficacy endpoint (time to first tolerated meal), the ipamorelin group showed reduced median time to first tolerated meal (25.3 hours versus 32.6 hours in placebo) and had fewer overall treatment-emergent adverse events (87.5% versus 94.8%)

Most researchers settle on 100 mcg at each dosing time as a starting point

A band-aid or bandage in case you want to cover the area where the injection was given

We combine advanced peptide therapies with a commitment to safety and patient education